S&P 500   3,012.97 (+0.21%)
DOW   26,840.93 (+0.05%)
QQQ   194.03 (+0.33%)
AAPL   240.96 (+0.19%)
FB   190.33 (+0.30%)
MSFT   139.48 (+0.76%)
GOOGL   1,245.26 (+0.08%)
AMZN   1,776.41 (-0.52%)
CGC   20.47 (+0.59%)
NVDA   198.19 (+1.11%)
BABA   173.79 (+0.16%)
GE   8.64 (-1.71%)
TSLA   253.79 (+0.11%)
AMD   31.88 (-0.47%)
T   37.95 (-0.73%)
F   8.99 (-0.44%)
ACB   3.63 (-1.63%)
PRI   124.94 (-0.60%)
NFLX   269.84 (-2.96%)
BAC   30.96 (-0.19%)
GILD   66.24 (+1.58%)
DIS   132.53 (+1.74%)
S&P 500   3,012.97 (+0.21%)
DOW   26,840.93 (+0.05%)
QQQ   194.03 (+0.33%)
AAPL   240.96 (+0.19%)
FB   190.33 (+0.30%)
MSFT   139.48 (+0.76%)
GOOGL   1,245.26 (+0.08%)
AMZN   1,776.41 (-0.52%)
CGC   20.47 (+0.59%)
NVDA   198.19 (+1.11%)
BABA   173.79 (+0.16%)
GE   8.64 (-1.71%)
TSLA   253.79 (+0.11%)
AMD   31.88 (-0.47%)
T   37.95 (-0.73%)
F   8.99 (-0.44%)
ACB   3.63 (-1.63%)
PRI   124.94 (-0.60%)
NFLX   269.84 (-2.96%)
BAC   30.96 (-0.19%)
GILD   66.24 (+1.58%)
DIS   132.53 (+1.74%)
Log in

Adverum Biotechnologies SEC Filings & 10K Form (NASDAQ:ADVM)

$7.26
+0.18 (+2.54 %)
(As of 10/22/2019 10:08 AM ET)
Today's Range
$7.11
Now: $7.26
$7.30
50-Day Range
$5.02
MA: $7.12
$12.40
52-Week Range
$2.62
Now: $7.26
$16.38
Volume820 shs
Average Volume1.51 million shs
Market Capitalization$467.98 million
P/E RatioN/A
Dividend YieldN/A
Beta2.49

SEC Filings

Adverum Biotechnologies (NASDAQ:ADVM) SEC Filings

DateFilerForm TypeView
09/12/2019
5:05 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:58 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
3:17 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:16 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:15 PM
Adverum Biotechnologies (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:36 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
3:35 PM
Adverum Biotechnologies (Filer)
Form S-3ASR
08/08/2019
3:07 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:27 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:26 PM
Adverum Biotechnologies (Issuer)
Spivey Richard N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:26 PM
Adverum Biotechnologies (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:25 PM
Adverum Biotechnologies (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:24 PM
Adverum Biotechnologies (Issuer)
Finer Mitchell H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:23 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:22 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:21 PM
Adverum Biotechnologies (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
3:59 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:03 PM
Adverum Biotechnologies (Filer)
Form DEFA14A
06/17/2019
3:02 PM
Adverum Biotechnologies (Filer)
Form DEF 14A
05/30/2019
11:16 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Adverum Biotechnologies (Subject)
Form SC 13G
05/08/2019
3:13 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
6:42 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
3:34 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2019
3:33 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2019
3:32 PM
Adverum Biotechnologies (Issuer)
Hemrajani Rekha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2019
3:21 PM
Adverum Biotechnologies (Subject)
Sonic Fund II, L.P. (Filed by)
Form SC 13D/A
05/02/2019
3:37 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
8:38 PM
Adverum Biotechnologies (Filer)
Form 10-K/A
04/25/2019
4:05 PM
Adverum Biotechnologies (Issuer)
Leung Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
4:01 PM
Adverum Biotechnologies (Issuer)
Leung Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2019
3:22 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
3:44 PM
Adverum Biotechnologies (Issuer)
Osborne Aaron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2019
2:58 PM
Adverum Biotechnologies (Subject)
Sonic Fund II, L.P. (Filed by)
Form SC 13D
03/19/2019
8:36 AM
Adverum Biotechnologies (Filer)
Form CT ORDER
03/12/2019
3:16 PM
Adverum Biotechnologies (Filer)
Form S-8 POS
03/07/2019
4:18 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2019
4:31 PM
Adverum Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2019
3:06 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
3:15 PM
Adverum Biotechnologies (Issuer)
PATTERSON LEONE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
11:29 AM
Adverum Biotechnologies (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/14/2019
8:18 AM
Adverum Biotechnologies (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2019
12:33 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Adverum Biotechnologies (Subject)
Form SC 13G/A
11/16/2018
9:48 AM
Adverum Biotechnologies (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/08/2018
4:21 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2018
3:16 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
3:17 PM
Adverum Biotechnologies (Issuer)
PATTERSON LEONE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2018
3:25 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
3:24 PM
Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/02/2018
3:16 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2018
3:39 PM
Adverum Biotechnologies (Issuer)
Gasmi Mehdi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:38 PM
Adverum Biotechnologies (Issuer)
Cheng Jennifer C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:37 PM
Adverum Biotechnologies (Issuer)
PATTERSON LEONE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:41 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:38 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:30 PM
Adverum Biotechnologies (Issuer)
Spivey Richard N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:28 PM
Adverum Biotechnologies (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:27 PM
Adverum Biotechnologies (Issuer)
Woiwode Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:26 PM
Adverum Biotechnologies (Issuer)
Finer Mitchell H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:25 PM
Adverum Biotechnologies (Issuer)
Cleveland Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:49 PM
Adverum Biotechnologies (Filer)
Form DEFA14A
05/03/2018
3:36 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
3:09 PM
Adverum Biotechnologies (Filer)
Form DEFA14A
04/20/2018
3:07 PM
Adverum Biotechnologies (Filer)
Form DEF 14A
04/16/2018
3:40 PM
Adverum Biotechnologies (Filer)
Form CT ORDER
03/23/2018
4:04 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/22/2018
4:23 PM
Adverum Biotechnologies (Filer)
Form 8-K/A
03/06/2018
4:12 PM
Adverum Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2018
6:19 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
6:18 PM
Adverum Biotechnologies (Issuer)
Cheng Jennifer C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
6:17 PM
Adverum Biotechnologies (Issuer)
PATTERSON LEONE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
6:17 PM
Adverum Biotechnologies (Issuer)
Gasmi Mehdi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
6:16 PM
Adverum Biotechnologies (Issuer)
Countouriotis Athena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
6:15 PM
Adverum Biotechnologies (Issuer)
Salzman Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
10:11 AM
Adverum Biotechnologies (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/12/2018
1:03 PM
Adverum Biotechnologies (Subject)
Bpifrance Participations SA (Filed by)
Form SC 13G/A
02/08/2018
4:31 PM
Adverum Biotechnologies (Filer)
Form 424B5
01/26/2018
7:46 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2018
3:17 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2017
4:04 PM
Adverum Biotechnologies (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
12/05/2017
8:12 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel